International Webinar: the detection and treatment of ALK fusion-positive NSCLC
Dr Ross et al in a discussion on the detection and treatment of ALK fusion-positive NSCLC in current practice
Published 31/01/24
You are about to leave Roche4Med website. Links to external web pages are offered for your convenience. Roche Pharmaceuticals (Israel) Ltd. is not responsible for the content displayed on those pages.